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Background. Health service coverage cascades measure the proportion of a population in need of a service that experienced a positive health 
outcome from the service, and enable tracking of progress in achieving universal health coverage and inequities in care coverage.
Objectives. To investigate HIV care coverage among HIV-positive adolescent girls and young women (AGYW) living in six South African 
districts, compare coverage by age and socioeconomic status (SES), and investigate other associated factors including participation in a 
combination HIV prevention intervention.
Methods. The HERStory Study was an evaluation of the combination intervention, comprising a representative household survey of 
AGYW aged 15 - 24 years living in six intervention districts. From September 2017 to November 2018, biological, sociodemographic and 
behavioural data were collected. HIV-positive status, initiation of antiretroviral therapy (ART) and viral suppression were determined 
through laboratory tests (enzyme-linked immunosorbent assay for HIV antibodies, antiretroviral (ARV) metabolites and viral load (VL) 
testing). Viral suppression was defined as a VL <1 000 copies/mL. Knowledge of HIV-positive status was self-reported, and participants 
testing positive for ARV metabolites were assumed to have known their HIV-positive status. Unconditional HIV care cascades were created, 
stratified by age and SES. We used Pearson’s χ2 tests corrected for survey-based analysis to describe factors associated with knowledge of 
HIV status, and being on ART.
Results. Of the 4 399 participants, 568 were HIV-positive (12.4%), of whom 60.8% (95% confidence interval (CI) 57.1 - 64.5) knew their status, 
50.6% (95% CI 46.6 - 54.0) were on ART, and 62.1% (95% CI 58.4 - 65.9) were virally suppressed. Most participants (84.9%) were in the lower 
SES group, and they had better coverage than the higher SES group: 61.9% (95% CI 58.3 - 65.4) knew their status, 52.1% (95% CI 48.4 - 55.9) 
were on ART, and 64.9% (95% CI 61.3 - 68.4) were virally suppressed, compared with 55.0% (95% CI 42.1 - 68.0), 40.0% (95% CI 29.2 - 50.8), 
and 46.6% (95% CI 34.5 - 58.7), respectively. Participants aged 15 - 19 years had slightly inferior coverage to the 20 - 24-year-old group: 57.5% 
knew their status, 46.1% were on ART and 59.5% were virally suppressed, compared with 62.3%, 52.2% and 63.3%.
Conclusions. These findings emphasise the need to close the gaps in HIV care coverage among AGYW, of whom only 61% knew their HIV-
positive status and only 62% were virally suppressed. There is pro-poor inequality in HIV care coverage, with those in lower socioeconomic 
groups more likely to be virally suppressed.
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Health interventions during adolescence and young adulthood have 
the potential to generate a triple dividend: improved health during 
adolescence and young adulthood, during later adulthood, and for 
the next generation.[1,2] For adolescents (aged 10 - 19 years) and 
young people (aged 20 - 24 years) living with HIV, who are among 
the most vulnerable populations,[3] HIV diagnosis and treatment 
interventions have the potential to reduce mortality, improve health 
and wellbeing, and halt transmission to other individuals. However, 
adolescents and young people have had inadequate access to HIV 
diagnosis and treatment, which contributes to avoidable AIDS-
related morbidity and deaths.[4] For example, compared with adults 
on antiretroviral therapy (ART), adolescents diagnosed with HIV 
have poorer adherence to ART[5] and are the only age group with 
increasing HIV mortality.[6]
South Africa (SA) has the world’s largest ART programme, 
which has increased life expectancy and saved lives,[7] as well as 
cut maternal-to-child transmission (MTCT) of HIV from 25 - 30% 
before 2001 to 1.4% in 2016.[8] However, SA adolescents and young 
people are less likely than adults to benefit from HIV interventions, 
and are less likely to be diagnosed and to know their HIV positive 
status compared with older people,[9] many with HIV do not start 
ART,[10] and more than half of HIV-positive young men and women 
aged 15 - 24 years are not virally suppressed.[9] Compared with adult 
mothers, adolescent mothers living with HIV are more likely to have 
unplanned pregnancies and less likely to access interventions to 
prevent MTCT.[11]
Combination HIV prevention and care interventions, which merge 
effective biomedical, behavioural and structural interventions for 
combined delivery, are one of the key strategies for reaching the 90-90-
90 targets and achieving the Sustainable Development Goal (SDG) 
of ending the HIV epidemic by 2030.[12] Between 2016 and 2019, 
the Global Fund made an investment of USD67 million in a 3-year 
comprehensive combination HIV prevention and care programme for 
SA adolescent girls and young women (AGYW) aged 10 - 24 years. The 
intervention was implemented by government and non-government 
organisations in 10 districts in which young women were at high risk 
of HIV acquisition and in which there was no other large-scale HIV 
prevention intervention. In each district, the intervention was targeted 
to selected subdistricts, areas or wards where it was determined that 
risk of HIV was highest. Key intervention components were Soul 
Buddyz Clubs[13] for adolescent girls and boys aged 10 - 14 years in 
primary schools, the Keeping Girls in School (KGS) programme for 
AGYW aged 14 - 18 years in high schools (https://www.mietafrica.
com/projects-programmes/youth-development/keeping-girls-in-
school-kgs/), RISE Clubs for AGYW in school aged 15 - 19 years, and 
RISE Clubs and Women of Worth Clubs for AGYW out of school aged 
19 - 24 years. HIV testing and linkage to HIV prevention and care 
services were offered through the Club and KGS programmes. HIV 
testing was also promoted indirectly, by referring AGYW to clinics. In 
some districts, young people were employed as clinic ‘navigators’ and 
placed in clinics to meet and welcome AGYW and to promote youth-
responsive clinic services.
Global initiatives such as the United Nations SDGs, the Lancet 
Commission on Adolescent Health and Wellbeing[1,2] and Countdown 
to 2030 have called attention to tracking progress in the health of 
adolescents and young people up to age 24 years. The concept of 
‘effective coverage’ (EC), defined as the proportion of a population 
in need of a service that experienced a positive health outcome from 
the service, is critical to measuring such progress.[14] Health service 
coverage cascades have been proposed as the most appropriate way to 
measure EC, and enable us to monitor progress in achieving universal 
health coverage and a high-quality health system.[14,15] They enable 
the measurement of inequities in care coverage: as HIV care coverage 
increases, there may be uneven progress in reaching subpopulations, 
and inequities may remain or even increase.[16] It is important 
to monitor disparities in access to care by socioeconomic status 
(SES). Socioeconomic inequalities are associated with inequities 
in sexual and reproductive health (SRH) among adolescents. For 
example, in sub-Saharan Africa, poorer adolescent girls (compared 
with wealthier) face more barriers in meeting their SRH needs and 
are more likely to have their first sexual encounter and to start 
childbearing at a younger age.[17]
Objectives
We used HIV care coverage cascades stratified by age and SES to 
describe the coverage of HIV care services among AGYW aged 
15 - 24 years living in geographical areas in which the combination 
intervention was implemented. We also investigated whether age, 
SES (poverty level), being in high school, having a deceased parent, 
recency of HIV infection, and participation in key components of the 
combination intervention were associated with care coverage.
Methods
Study design and sampling
The data were generated from the HERStory Study, an evaluation 
of the combination intervention. For these analyses, the design was 
a cross-sectional, representative household survey of AGYW aged 
15 - 24 years living in six of the 10 districts in which the combination 
HIV prevention intervention was implemented: City of Cape Town 
(Western Cape Province), Ehlanzeni (Mpumalanga Province), 
OR  Tambo (Eastern Cape Province), Tshwane (Gauteng Province), 
King Cetshwayo and Zululand (KwaZulu-Natal Province). The 
survey began in 2017, ~18 months after the start of the intervention, 
and it was completed in 2018, 32 months after implementation 
started.
We used a stratified cluster sampling design, with three stages of 
sampling. First, we took a simple random sample of census, small 
area layers (SALs) within the sub-areas in which the intervention 
was implemented in each district. Then we conducted a systematic 
random sample of 35% of households within each SAL. Finally, 
all AGYW aged 15 - 24 years in each household were invited to 
participate in the study. If the members of a selected household 
declined to participate, we did not replace the household. Our 
original sample size calculation of 14 000 AGYW, in 10 districts 
(Table 1), was based on being able to measure a difference in HIV 
incidence over 2 years using cross-sectional data.[18] However, the 
survey could only be completed in six districts within the time 
allocated to the study, and the four districts scheduled last for data 
collection were not completed.
Measures
We used electronic questionnaires developed using the Mobenzi 
Researcher data collection software suite (https://www.mobenzi.
com/researcher/home), administered using a tablet. Demographic, 
socioeconomic and behavioural data were collected from all enrolled 
participants using these structured electronic questionnaires 
administered by trained fieldworkers.
The questionnaire included a number of categorical variables 
related to SES:[19] (i) AGYW was away from home for more than 
1  month in the past 12 months (internal migration has been 
shown to cause and be caused by poverty;[20] (ii) has piped water in 
household; (iii) has a flushing toilet in household; (iv) household 
has working electricity; (v) household has a car; (vi) household 
has a computer; (vii) household has internet; (viii) household has 
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a refrigerator; (ix)  household has a stove; 
(x)  AGYW or household member went a 
day/night without eating in the past month; 
(xi) AGYW has own money; (xii) AGYW 
saves money; and (xiii) AGYW owes money.
We asked about participation in the 
key components of the combination HIV 
prevention intervention, which were branded 
and therefore easy to identify. A participant 
was defined as having participated if she 
reported ever attending or being a member 
of Soul Buddyz or RISE or Women of Worth, 
or had ever attended a KGS health education 
or homework support session.
The HIV status of participants was deter-
mined using blood samples that were 
analysed in a laboratory. The samples were 
tested with the Bio-Rad HIV1/2 Combo 
Assay (Genscreen, France)  and any reac-
tive result was confirmed by a second 
4th-generation test (HIV1/2 COMBI COBAS 
E411 (Roche Diagnostics, Germany). All 
positive specimens were confirmed for 
HIV-1 infection by Western blot (GS HIV-1 
Western Blot, Bio-Rad Laboratories, USA).
To distinguish recent HIV infection, we 
used a limiting antigen avidity immunoassay 
(LAg EIA; Maxim Biomedical, USA). 
Specimens confirmed by Western blot to 
be HIV-positive were tested to determine 
recent or early v. long-term HIV infection 
using the single-well LAg-Avidity EIA test 
(Maxim Biomedical). Recent HIV infections 
had a mean duration of 161 days. The HIV-1 
RNA viral load (VL) assay and ART drug 
measurements were included in a recent 
infection testing algorithm to minimise the 
false recent rate, to determine the proportion 
of HIV-infected persons on ART and those 
who were ART naive with detectable and 
undetectable VLs.
Participants were asked whether they had 
ever had an HIV test, and if yes, what 
their test result was at the most recent 
test. Later in the questionnaire, they were 
asked whether they knew their HIV status 
(negative, positive, unknown). Participants 
were classified as having knowledge of their 
HIV-positive status if they answered that 
they were positive in either of those two 
questions. In addition, they were assumed to 
have knowledge of their status if a laboratory 
test confirmed that they were positive and 
antiretroviral (ARV) metabolites were 
present in their blood.
ART testing was performed on HIV 
serology-positive specimens for measure-
ment of ARVs that were in use in either 
first- or second-line regimens in the public 
sector. Antiretroviral testing was performed 
using dry blood spots (DBSs) determined by 
high-performance liquid chromatography 
(HPLC) coupled with tandem mass spectro-
metry (HPLC-Module 1260 Infinity 11 
(Agilent Technologies Inc., Germany), mass 
spectrometer ABSciex 6.5+ (USA). The 
assay was a validated qualitative detection 
of nevirapine, emtricitabine, lamuvidine, 
abacavir and tenofovir (the lower limit of 
detection was 25 ng/mL/0.025  µg/mL), 
efavirenz, and lopinavir (lower limit of 
detection 100 ng/mL/0.1 µg/mL). Known 
standards were analysed with every batch 
of samples to ensure reproducibility and 
adequate quality assurance. If any metabolite 
was detected in their blood, the participant 
was considered to have ART exposure.
To determine VL, HIV-1 VL testing was 
performed on all confirmed HIV-positive 
specimens using the Abbott m2000 HIV 
Real-Time System (Abbott Molecular Inc., 
USA). Viral suppression was defined as a 
cut-off ≤1 000 copies/mL.
Procedures
The field team identified the sampled house-
holds using aerial maps, and determined 
the geographical co-ordinates using the 
Global Positioning System (GPS). If the 
selected household was vacant, there was no 
AGYW in the household, or the household 
head declined to complete a household 
listing form to determine whether there 
were eligible AGYW, the household on the 
right was visited and assessed for eligibility. 
Only one eligible household was enrolled 
at the random point selected through 
this approach. We obtained consent from 
AGYW, and parental consent for AGYW 
<18 years of age. Trained fieldworkers first 
administered the survey to consenting 
AGYW. The sections of the questionnaire 
with questions about sexuality, HIV testing 
and HIV status were completed by the 
participants themselves to diminish social 
desirability bias. The fieldworker read each 
question to the participant and allowed 
the participant to enter her responses in 
the tablet privately. Then the fieldworker 
collected two microtainers of whole blood 
using a finger prick. After the questionnaire 
had been completed and specimens 
collected, participants were offered rapid 
HIV testing in the household. Microtainers 
of blood were shipped daily to the laboratory 
for preparation of DBSs and centrifugation 
to obtain plasma. Specimens not shipped 
on the same day were stored at 4 - 8°C until 
shipped the next day. Participants were 
reimbursed with a gift and voucher to the 
value of ZAR75 (USD5) to compensate 
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visit their nearest clinic 2 weeks after their partici pation to obtain 
the results of the study laboratory tests, using a bar-coded referral 
card. The study was approved by the South African Medical 
Research Council Research Ethics Committee (ref. no. EC036-
11/2016) and by the Center for Global Health Associate Director 
for Science, US Centers for Disease Control and Prevention (CDC) 
(ref. no. CGH 2017-194a).
Analysis
The analyses were restricted to participants who tested HIV-positive 
in the study laboratory tests (n=568), except for a description of 
the HIV prevalence in the study population. Since the aim was to 
generalise study results to the broader population of AGYW across 
all six districts and interpret the estimates as true population-level 
estimates, we incorporated sample weights into the analysis, and all 
estimates are weighted. The sample weights take into account the 
probability of sampling SALs in each district and the systematic 
probability of sampling households within each SAL. Survey-based 
analysis was performed with the six districts specified as survey strata, 
and SALs as the primary sampling unit. Finite population sampling 
estimation was used in the survey analysis to improve the precision 
of the estimates, and the number of SALs in each district was used for 
this approach.
We produced overall and stratified unconditional HIV care 
cascades for the HIV-positive AGYW in the study. The cascades 
presented here summarise: (i) the proportion of HIV-positive AGYW 
who know their status (‘status known’); (ii) the proportion of HIV-
positive AGYW who had ARV metabolites detected in their blood 
(‘on ART’); and (iii) the fraction of HIV-positive AGYW who were 
virally suppressed (‘virally suppressed’). The HIV care cascades are 
‘unconditional’ because each proportion across the cascade uses the 
number of HIV-positive AGYW in the denominator.
Stratification variables included age group (15 - 19/20 - 24 years) 
and SES (relatively low/relatively high). A participant’s SES group was 
determined using cluster analysis with the K-modes algorithm,[21] 
with the 13 SES questions described above. Cluster analysis is an 
exploratory and unsupervised machine learning technique that 
allows analysts to divide data into meaningful groups based upon 
shared features. For further details about the SES variable, see 
Appendix A (available as a supplementary file at http://samj.org.za/
public/sup/15351.pdf).
HIV-positive participants were characterised by calculating 
descriptive statistics for the overall population and by knowledge of 
their HIV status. We also described the participants who were HIV-
positive and knew their status, by ART status. For these bivariate 
analyses, Pearson’s χ2 test was used, corrected for the survey-based 
analysis to describe whether age group, SES group, orphanhood 
(one or both parents deceased), being in school, recency of HIV 
infection, and self-reported participation in the AGYW combination 
intervention were associated with knowledge of HIV status, and 
being on ART. Risk differences and their 95% confidence intervals 
(CIs) were also calculated for each of these bivariate analyses.
Stata 15.1 (StataCorp, USA) and R version 3.5.0 (R Core Team, 
Austria) were used to perform the analyses.[22] In R the ‘survey’ and 
‘srvyr’ packages were used for the survey-based analyses.[23,24] The 
package ‘klaR’ was used for the cluster analysis.[25]
Results
Sampling realisation and response rates  
of participants
The data were collected during 2017 - 2018. In the six districts, 
we sampled 7 300 AGYW and visited 22 388 households. All the 
primary sampling units were visited in each of the districts (Table 1). 
The number of households visited met the target, but the number of 
ineligible households was higher in the urban-based districts, which 
led to a lower sample realisation. The overall sample realisation of 
participants was 60.6% in the six completed districts. Ultimately, 
4 436 AGYW completed the survey, and 4 399 were in the age range, 
were enrolled in the study and were weighted to the total sample size 
of 7 300.
Table 2. Characteristics of the sample (N=568) of HIV-positive adolescent girls and young women aged 15 - 24 years in six districts 
in South Africa, 2017 - 2018*
Characteristics n (%) 95% CI
Age group (years)
15 - 19 185 (30.9) 27.9 - 34.1
20 - 24 383 (69.1) 65.9 - 72.1
Currently in school
No 354 (64.6) 61.3 - 67.9
Yes 214 (35.4) 32.1 - 38.7
Has a deceased parent†
No 219 (39.2) 35.9 - 42.6
Yes 345 (60.8) 57.4 - 64.1
Socioeconomic status
Relatively low socioeconomic group 490 (84.9) 81.1 - 88.2
Relatively high socioeconomic group 78 (15.1) 11.8 - 18.9
Self-reported exposure to a Global Fund intervention
No 334 (56.8) 53.1 - 60.4
Yes 234 (43.2) 39.6 - 46.9
Recent HIV infection
No 542 (95.5) 94.0 - 96.7
Yes 26 (4.5) 3.3 - 6.0
CI = confidence interval.
*All estimates are weighted.
†There were four missing observations for this variable.
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Characteristics of participants
Of the 4 399 participants in the broader 
study, 568 were HIV-positive (12.4%) and 
comprised the study population for the 
analyses reported here. Most of the HIV-
positive participants were in the 20 - 24-year 
age range (69.1%), 35.4% were enrolled in 
high school, 84.9% fell into the relatively 
low SES group, and 43.2% reported they 
had participated in a key component of the 
combination HIV prevention intervention 
(Table 2). We classified 4.5% of participants 
as having recently been infected with HIV.
Overall HIV care coverage
Of all 568 participants with laboratory-
confirmed HIV-positive status, 60.8% (95% 
CI 57.1 - 64.5) knew their status, 50.3% 
of 568 (95% CI 46.6 - 54.0) were on ART, 
and 62.1% of 568 (95% CI 58.4 - 65.9) were 
virally suppressed (Fig. 1). Interestingly, 
there was a higher fraction of AGYW who 
were virally suppressed, than of AGYW who 
knew their status.
Age-stratified HIV care coverage
A slightly smaller fraction of participants in 
the younger age group knew their HIV status 
(57.5%; 95% CI 52.1 - 62.8) compared with 
the older age group (62.3%; 95% CI  57.6  - 
67.0) (Fig. 2). Only 46.1% (95% CI  40.5  - 
51.7) of younger HIV-positive AGYW 
were on ART compared with 52.2 (95% 
CI 47.7 - 56.7) of older HIV-positive AGYW. 
Following a similar pattern, 59.5% (95% 
CI 54.1 - 64.8) of AGYW aged 15 - 19  years 
were virally suppressed, while 63.3% (95% 
CI 58.4 - 68.2) of AGYW aged 20 - 24 years 
were virally suppressed.
SES-stratified HIV care coverage
In Fig. 3, the HIV care cascades, disaggre-
gated by level of SES, show that participants 
in the lower SES group had better HIV care 
cascades: 61.9% (95% CI 58.3 - 65.4) knew 
their status, 52.1% (95% CI 48.4 - 55.9) were 
on ART, and 64.9% (95% CI 61.3 - 68.4) were 
virally suppressed, compared with 55.0% 
(95% CI 42.1 - 68.0), 40.0% (95% CI 29.2 - 
50.8) and 46.6% (95% CI 34.5 - 58.7), 
respectively, in the relatively high SES group. 
The differences were most pronounced for 
viral suppression, indicating higher levels 
of care coverage for the relatively low SES 
group.
HIV care coverage stratified by age 
and SES
Participants in the older age and relatively 
high SES group had the worst cascades 
(Fig.  4). Approximately half in this group 
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Fig. 1. HIV care coverage among 568 adolescent girls and young women aged 15 - 24 years in six 
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Fig. 2. HIV care coverage among 568 adolescent girls and young women aged 15 - 24 years in six districts in 
South Africa, 2017 - 2018, stratified by age group. (CI = confidence interval; ART = antiretroviral therapy.)
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thirds were not on treatment. Those in the 
older age group who were in the relatively 
low SES group had the best outcomes, with 
64.4% knowing their status, 55.4% being on 
treatment and 66.5% being virally suppressed.
Factors associated with HIV care 
coverage
Table 3 examines differences between parti-
cipants who knew about their HIV-positive 
status v. those who did not. Among HIV-
positive AGYW, 54.5% (95% CI 49.0 - 59.9) 
who did not have a deceased parent knew 
their status v. 64.5% (95% CI 59.2 - 69.5) 
of those with a deceased parent, with a 
risk difference of 10.0% (95% CI 2.8 - 17.2). 
Those who had recently been infected with 
HIV had 55.2 fewer instances of knowing 
their status per 100 AGYW (95% CI –64.1 - 
–46.2), compared with those with long-term 
infections (63.3% v. 8.2%; p<0.000).
To develop hypotheses about why people 
who knew their HIV-positive status were not 
on ART, a description of these participants 
is presented in Table 4. Overall, 358 
participants were HIV-positive and knew 
their HIV status, and 57 of these were not 
on ART. In this subpopulation, 84.8% (95% 
CI 81.2 - 87.9) of those in the low-SES group 
were on ART v. 72.6% (95% CI 61.2 - 82.2) 
of those in the high-SES group, a difference 
of 12.15% (95% CI  –22.52 - –1.79). There 
were ~6 more AGYW on ART per 100 
(95% CI  0.19 - 12.04) among those who 
participated in the combination intervention 
compared with those who did not participate 
(86.7% v. 80.6%).
Discussion
The study findings emphasise the weak-
nesses in the continuum of care for HIV-
positive AGYW, of whom 39% did not know 
their HIV-positive status and therefore 
would not have had access to HIV treatment. 
Participants who were recently infected 
were less likely to know their HIV status, 
which highlights the importance of regular 
HIV testing to reduce rates of undiagnosed 
infection. AGYW who had a deceased 
parent were more likely to know their HIV 
status. HIV is a common underlying cause 
of orphanhood, and orphans are more likely 
to be HIV-positive than children who are not 
orphaned.[26] It is likely that young people 
who have lost a parent to HIV have had their 
own HIV diagnosed through the process of 
their parent’s diagnosis or death.
To achieve the Joint United Nations 
Programme on HIV and AIDS (UNAIDS) 
target for the third ‘90’, we need to achieve 
viral suppression in 73% of the population of 
HIV-positive AGYW. We have demonstrated 
a gap in HIV care coverage, with only 
62.1% of the AGYW in our study virally 
suppressed. Nevertheless, the level of care 
coverage among AGYW in our study 
population, which was receiving an HIV 
combination prevention intervention, is 
substantially higher than the estimates from 
a nationally representative survey conducted 
in 2017, which found that only 47.7% of 
all HIV-positive AGYW aged 15 - 24 years 
were virally suppressed.[9] The substantially 
higher estimates in our study raise the 
question about whether the combination 
HIV prevention intervention, which was 
being implemented at the time of the survey, 
may have been contributing to closing gaps 
in HIV care coverage. Supporting this, we 
found that a higher fraction of participants 
on ART had participated in the combination 
HIV intervention compared with those not 
on ART. However, our study design does not 
enable us to draw conclusive evidence about 
the intervention effect.
Adolescents (aged 15 - 19 years) had 
slightly poorer levels of care coverage than 
young women aged ≥20 years of age. This 
is consistent with other studies that show 
the difficulty of achieving EC of HIV care 
among adolescents in SA and sub-Saharan 
Africa. [4-6,27] We found that AGYW in the 
lower SES group had substantially better levels 
of care coverage than those in the higher SES 
group. A similar pro-poor inequality in care 
coverage has been observed in the uptake 
of HIV testing among pregnant women in 
SA.[28] A possible explanation is that AGYW 
who were employed were more likely to be in 
the higher SES group and had little time away 
from work to access HIV services. Another 
possible explanation is that the free HIV care 
services provided by the public sector were 
more acceptable to AGYW in the lower SES 
group compared with those in the higher SES 
group, while at the same time private sector 
HIV care services were not accessible to 
either group. The disparities in levels of care 
coverage by SES group suggest that efforts to 
make services more youth-friendly need to 
consider the accessibility, acceptability and 








































Relatively low SES                                                             Relatively high SES 
Fig. 3. HIV care coverage among 568 adolescent girls and young women aged 15 - 24 years in six 
districts in South Africa, 2017 - 2018, stratified by SES. (SES = socioeconomic status; CI = confidence 
interval; ART = antiretroviral therapy.)
466       May 2021, Vol. 111, No. 5
RESEARCH
Study limitations
Some participants were virally suppressed 
but did not know their HIV status, based 
on our measures of knowledge of HIV 
status. Furthermore, some participants were 
determined to be virally suppressed, but 
ARVs were not detected in their blood, a 
phenomenon observed elsewhere.[9] There 
are several possible explanations for these 
observations, including imperfect sensitivity 
of laboratory tests to detect ART. Another 
possible reason is that the progression 
of HIV in the absence of ART includes 
periods of time when the VL is lower than 
the threshold used for determining viral 
suppression.[29] Furthermore, AGYW may be 
treated with ART by parents/guardians and 
not know their HIV status.
The cross-sectional study design limits our 
ability to attribute the higher levels of care 
coverage observed in the study population 
(compared with the national average) to the 
HIV prevention intervention that was being 
implemented. Furthermore, the survey was 
conducted during the 2nd and 3rd years of 
the intervention, and the intervention may 
not have had time to demonstrate impact on 
care coverage. The validity of participants’ 
reports of participation in the intervention 
in unknown. The sample realisation of 61% 
is a limitation, but it compares well with 
the 2016 South African Demographic and 
Health Survey response rate (56% among 
15 - 19-year-olds and 57% among 20 - 
24-year-old women selected to provide 
samples for HIV testing).[30]
Conclusions
These findings emphasise weaknesses in 
HIV care for AGYW in these study districts, 
of whom 39% did not know their HIV-
positive status and would not have access to 
treatment. To achieve the UNAIDS target for 
the third ‘90’ (viral suppression among 90% 
of those who know their status and are on 
ART), viral suppression needs to be achieved 
in 73% of the population of HIV-positive 
AGYW. This study has demonstrated a gap 
in care coverage, with only 62.1% of the 
AGYW study population virally suppressed. 
Special efforts are needed to improve care 
coverage for adolescent girls and AGYW in 
the higher SES group, who have relatively 
low levels of HIV care coverage.
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Fig. 4. HIV care coverage among 568 adolescent girls and young women aged 15 - 24 years in six 
districts in South Africa, 2017 - 2018, stratified by age group and SES. (SES = socioeconomic status; 
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